Microrna-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Yamamura, Soichiro ^a   Saini, Sharanjot ^a   Majid, Shahana ^a   Hirata, Hiroshi ^a   Ueno, Koji ^a   Deng, Guoren ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 34A; MYC PROTEIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN; SCATTER FACTOR RECEPTOR;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CANCER INVASION; CELL MOTION; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICE; MICRORNAS; NEOPLASM INVASIVENESS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENE PROTEINS C-MYC; RHOA GTP-BINDING PROTEIN; TRANSCRIPTION, GENETIC;

EID: 84855334413     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029722     Document Type: Article

References (51)

1. Brodersen P, Voinnet O, (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10: 141-148.
2. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
3. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
4. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
5. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
6. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
7. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, et al. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69: 7569-7576.
8. Welch C, Chen Y, Stallings RL, (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022.
9. Adhikary S, Eilers M, (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645.
10. Cole MD, Cowling VH, (2008) Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol 9: 810-815.
11. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
12. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
13. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, et al. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23: 2839-2849.
14. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, et al. (2010) p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A 107: 5375-5380.
15. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, et al. (2010) p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 17: 236-245.
16. Etienne-Manneville S, Hall A, (2002) Rho GTPases in cell biology. Nature 420: 629-635.
17. Heasman SJ, Ridley AJ, (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9: 690-701.
18. Jaffe AB, Hall A, (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21: 247-269.
19. Hodge JC, Bub J, Kaul S, Kajdacsy-Balla A, Lindholm PF, (2003) Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion. Cancer Res 63: 1359-1364.
20. Cardone RA, Bagorda A, Bellizzi A, Busco G, Guerra L, et al. (2005) Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol Biol Cell 16: 3117-3127.
21. Xia M, Land H, (2007) Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol 14: 215-223.
22. Chan CH, Lee SW, Li CF, Wang J, Yang WL, et al. (2010) Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 12: 457-467.
23. Peterlin BM, Price DH, (2006) Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23: 297-305.
24. Bres V, Yoh SM, Jones KA, (2008) The multi-tasking P-TEFb complex. Curr Opin Cell Biol 20: 334-340.
25. Eberhardy SR, Farnham PJ, (2002) Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 277: 40156-40162.
26. Kanazawa S, Soucek L, Evan G, Okamoto T, Peterlin BM, (2003) c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22: 5707-5711.
27. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, et al. (2010) c-Myc regulates transcriptional pause release. Cell 141: 432-445.
28. Lai AZ, Abella JV, Park M, (2009) Crosstalk in Met receptor oncogenesis. Trends Cell Biol 19: 542-551.
29. Trusolino L, Bertotti A, Comoglio PM, (2010) MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11: 834-848.
30. Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, et al. (2004) RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 64: 7962-7970.
31. Chen SY, Chen HC, (2006) Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol Cell Biol 26: 5155-5167.
32. Chung J, Yoon SO, Lipscomb EA, Mercurio AM, (2004) The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion. J Biol Chem 279: 32287-32293.
33. Jeffers M, Rong S, Vande Woude GF, (1996) Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115-1125.
34. Sridhar SC, Miranti CK, (2006) Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 25: 2367-2378.
35. Fujiuchi Y, Nagakawa O, Murakami K, Fuse H, Saiki I, (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol Rep 10: 1001-1006.
36. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, et al. (2008) Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119.
37. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600.
38. Tai S, Sun Y, Squires JM, Zhang H, Oh WK, et al. (2011) PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate 71: 1668-1679.
39. Eberhardy SR, Farnham PJ, (2001) c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem 276: 48562-48571.
40. Gargano B, Amente S, Majello B, Lania L, (2007) P-TEFb is a crucial co-factor for Myc transactivation. Cell Cycle 6: 2031-2037.
41. Li N, Fu H, Tie Y, Hu Z, Kong W, et al. (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 275: 44-53.
42. Yan D, Zhou X, Chen X, Hu DN, Dong XD, et al. (2009) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 50: 1559-1565.
43. Meyer N, Penn LZ, (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990.
44. Brooks TA, Hurley LH, (2009) The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics. Nat Rev Cancer 9: 849-861.
45. Land H, Parada LF, Weinberg RA, (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602.
46. Sahai E, Marshall CJ, (2002) RHO-GTPases and cancer. Nat Rev Cancer 2: 133-142.
47. Chao SH, Price DH, (2001) Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem 276: 31793-31799.
48. Zhou Q, Yik JH, (2006) The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol Mol Biol Rev 70: 646-659.
49. Mueller D, Garcia-Cuellar MP, Bach C, Buhl S, Maethner E, et al. (2009) Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol 7: e1000249.
50. Lin C, Smith ER, Takahashi H, Lai KC, Martin-Brown S, et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37: 429-437.
51. Moiola C, De Luca P, Gardner K, Vazquez E, De Siervi A, (2010) Cyclin T1 overexpression induces malignant transformation and tumor growth. Cell Cycle 9.